VetStem and PSC Press Releases

Published on May 14, 2020 - 13:00 GMT

New Patent for Stem Cells Issued to VetStem Biopharma

VetStem Biopharma was issued a new patent for using novel stem cell compositions in all mammals, including humans. POWAY, CALIFORNIA, USA, May 14, 2020 /⁨EINPresswire.com⁩/ -- Leading regenerative veterinary medicine company, VetStem Biopharma, has been issued a major patent that covers multiple methods of preparing and using novel stem cell compositions and kits comprising the same. This patent focuses on stem cell compositions from adipose (fat) tissue and covers all types of injury or disease in mammals …

Distribution channels: Chemical Industry, Companies ...

Published on April 23, 2020 - 16:23 GMT

COVID-19 Stem Cell Treatments – Urgent Charitable Donations Call

Donations needed to ramp up stem cell production to provide treatments for COVID-19 patients. POWAY, CALIFORNIA, UNITED STATES, April 23, 2020 /⁨EINPresswire.com⁩/ -- Personalized Stem Cells (PSC), a small, private biopharma company in San Diego, has repurposed its stem cell production team into making stem cell treatments for COVID-19 patients. Many COVID-19 patients are dying and currently there are no approved treatments for the severe pneumonia that occurs as a result of infection with COVID-19. PSC …

Distribution channels: Companies, Emergency Services ...

Published on April 21, 2020 - 13:00 GMT

CoronaStem 1 Trial - Personalized Stem Cells Files for Expedited FDA Approval to Treat COVID-19 Patients

Personalized Stem Cells, Inc. filed an FDA request for accelerated review of its COVID-19 stem cell treatment IND application. POWAY, CALIFORNIA, USA, April 21, 2020 /⁨EINPresswire.com⁩/ -- Personalized Stem Cells, Inc. (PSC) and its parent company, VetStem Biopharma, have filed an expedited review request for an Investigational New Drug (IND) application with the FDA for the treatment of COVID-19 patients with stem cells. The first trial is named “CoronaStem 1” and will provide treatment for twenty …

Distribution channels: Culture, Society & Lifestyle, Emergency Services ...

Published on April 14, 2020 - 14:00 GMT

VetStem Biopharma Shares the Success Story of Bender who was Treated with VetStem Cell Therapy by Dr. Mark Parchman

Bender, a feline, was successfully treated for kidney failure with VetStem Cell Therapy by Dr. Mark Parchman of Bend Veterinary Specialty and Emergency Center. POWAY, CALIFORNIA, UNITED STATES, April 14, 2020 /⁨EINPresswire.com⁩/ -- At just four years old, Bender, a domestic short haired feline, ingested an unknown poison that nearly killed him. As a result, he spent seven days on intravenous fluids in a 24-hour emergency animal hospital. In the four months that followed, Bender’s bloodwork showed …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on April 13, 2020 - 13:00 GMT

COVID-19 Emergency Stem Cell Treatment Collaboration in San Diego

Personalized Stem Cells, Inc. and Calidi Biotherapeutics collaborate to rapidly bring a stem cell therapy into clinical trials for COVID-19 patients. POWAY, CALIFORNIA, USA, April 13, 2020 /⁨EINPresswire.com⁩/ -- The scientific community is racing to bring new COVID-19 treatments to critical patients. Stem cell therapy is one of the few approaches that directly treats the lung inflammation caused by COVID-19 in these seriously ill patients in the ICU. The goal is reduction in ICU time, reduced ventilator …

Distribution channels: Business & Economy, Emergency Services ...

Published on March 10, 2020 - 13:00 GMT

VetStem Biopharma Shares the Success Story of Yoshio who was Treated with VetStem Cell Therapy by Dr. Kim Carlson

Yoshio, an Akita, was treated for arthritis in his hocks and carpus with VetStem Cell Therapy by Dr. Kim Carlson of North Peninsula Veterinary Surgical Group. POWAY, CALIFORNIA, US, March 10, 2020 /⁨EINPresswire.com⁩/ -- Yoshio, an Akita, has bilateral hock (ankle) dysplasia which caused painful osteoarthritis in the joints. He also has osteoarthritis in his right front carpus (wrist). At 9.5 years old, he was unable to jump on the bed or stand with his hocks at the proper angle. This caused discomfort …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on February 11, 2020 - 14:00 GMT

VetStem Biopharma Shares the Success Story of Opus who was Treated with VetStem Cell Therapy by Dr. Jerrold Bausman

Opus, a Shepherd, was treated for osteoarthritis in his hips with VetStem Regenerative Cell Therapy by Dr. Jerrold Bausman of VCA Vet Specialists of the Valley. POWAY, CALIFORNIA, USA, February 11, 2020 /⁨EINPresswire.com⁩/ -- Opus, a German Shepherd, was around six years old when he began to show symptoms of osteoarthritis in his hips. Opus was diagnosed with bilateral hip dysplasia and was prescribed pain medication as well as a nonsteroidal anti-inflammatory (NSAID) to help keep him comfortable. His …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on January 14, 2020 - 14:00 GMT

VetStem Biopharma Shares the Success Story of Trusty who was Treated with VetStem Cell Therapy by Dr Kristin Kirkby Shaw

Trusty was treated for osteoarthritis in his left elbow with VetStem Regenerative Cell Therapy by Dr. Kristin Kirkby Shaw of Animal Surgical Clinic of Seattle. POWAY, CALIFORNIA, US, January 14, 2020 /⁨EINPresswire.com⁩/ -- Trusty, a purebred Greater Swiss Mountain dog, lives on a 40-acre apple orchard in Washington. At just 14 weeks of age, Trusty walked with a slight limp. He also had difficulty going up and down stairs. His owners noted that even for his breed, he was on the larger side with a long …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...

Published on January 9, 2020 - 07:00 GMT

Personalized Stem Cells Chief Scientific Officer, Dr. Robert Harman, Recently Presented at Trauma Conference

Personalized Stem Cells, Inc. recently attended and presented at the Cellular Therapies and Transfusion Medicine in Trauma and Critical Care conference. POWAY, CALIFORNIA, USA, January 9, 2020 /⁨EINPresswire.com⁩/ -- Personalized Stem Cells, Inc (“PSC”), a human adipose-derived stem cell company, recently attended and presented at the Cellular Therapies and Transfusion Medicine in Trauma and Critical Care conference. The CTTACC conference took place on December 11-13, 2019 in San Diego, California. The …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...

The Newsroom of VetStem Biopharma/Personalized Stem Cells